Jacobson named NYU Langone Health director of hepatology

NYU Langone Health announced the appointment of Ira M. Jacobson, MD, as its new director of hepatology within its division of gastroenterology, according to a press release.

Ira M. Jacobson

“I am honored to join a division and institution where the mission of excellence in patient care, education, and research are embodied in every member of the team,” Jacobson said in the release. “I look forward to working with the group of hepatologists, surgeons, and other specialists who have done so much to build the outstanding program in liver diseases at NYU Langone.”

In his new position, Jacobson will work closely with NYU Langone Health’s Transplant Institute to identify and treat patients in need of liver transplant and will work to further the medical center’s active liver disease clinical research program.

Prior to joining NYU Langone Health, Jacobson was chair of the department of medicine at Mount Sinai Beth Israel, New York, and had previously served as chief of the division of gastroenterology and hepatology and as medical director of the Center for the Study of Hepatitis C at Weill Cornell, New York. Jacobson also serves as co-chief medical editor of HCV Next.

“Dr. Jacobson’s work has had a tremendous impact on the care of patients with hepatitis C, transforming this infection from a chronic disease to one that can be cured,” Mark B. Pochapin, MD, director of the NYU Langone Health division of gastroenterology, said in the release. “His recruitment to NYU Langone greatly enhances our ability to treat patients, strengthens our understanding of liver disease through research and broadens our education of the next generation of physicians.”

Reference: www.nyumc.org